@article{uoadl:3000189,
    volume = "11",
    journal = "Frontiers in Immunology",
    keywords = "diphtheria toxin;  hemagglutinin;  influenza vaccine;  neutralizing antibody;  pertussis vaccine;  virulence factor;  vaccine, adaptive immunity;  antibiotic prophylaxis;  antibody response;  Apgar score;  Bordetella pertussis;  cellular immunity;  disease surveillance;  female;  fetus outcome;  gestational age;  health care personnel;  hemagglutination inhibition;  hospitalization;  human;  Human respiratory syncytial virus;  humoral immunity;  immune response;  immunization;  immunogenicity;  intensive care unit;  pregnancy;  pregnant woman;  prenatal care;  prevalence;  questionnaire;  Review;  risk factor;  Rotavirus;  seroconversion;  syncytiotrophoblast;  vaccination;  vaccine immunogenicity;  vaginal delivery;  Zika virus;  adverse event;  clinical trial (topic);  consensus;  ethics;  global health;  health care planning;  health impact assessment;  immunology;  maternal exposure;  medical ethics;  pregnancy;  pregnancy complication;  prenatal exposure;  procedures;  research;  risk assessment, Clinical Trials as Topic;  Consensus;  Ethics, Medical;  Female;  Global Health;  Health Impact Assessment;  Health Priorities;  Humans;  Immunization;  Immunogenicity, Vaccine;  Maternal Exposure;  Pregnancy;  Pregnancy Complications, Infectious;  Prenatal Exposure Delayed Effects;  Research;  Risk Assessment;  Risk Factors;  Vaccination;  Vaccines",
    BIBTEX_ENTRY = "article",
    year = "2020",
    author = "Abu-Raya, B. and Maertens, K. and Edwards, K.M. and Omer, S.B. and Englund, J.A. and Flanagan, K.L. and Snape, M.D. and Amirthalingam, G. and Leuridan, E. and Damme, P.V. and Papaevangelou, V. and Launay, O. and Dagan, R. and Campins, M. and Cavaliere, A.F. and Frusca, T. and Guidi, S. and O'Ryan, M. and Heininger, U. and Tan, T. and Alsuwaidi, A.R. and Safadi, M.A. and Vilca, L.M. and Wanlapakorn, N. and Madhi, S.A. and Giles, M.L. and Prymula, R. and Ladhani, S. and Martinón-Torres, F. and Tan, L. and Michelin, L. and Scambia, G. and Principi, N. and Esposito, S. and World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Vaccine Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EVASG)",
    abstract = "Immunization during pregnancy has been recommended in an increasing number of countries. The aim of this strategy is to protect pregnant women and infants from severe infectious disease, morbidity and mortality and is currently limited to tetanus, inactivated influenza, and pertussis-containing vaccines. There have been recent advancements in the development of vaccines designed primarily for use in pregnant women (respiratory syncytial virus and group B Streptococcus vaccines). Although there is increasing evidence to support vaccination in pregnancy, important gaps in knowledge still exist and need to be addressed by future studies. This collaborative consensus paper provides a review of the current literature on immunization during pregnancy and highlights the gaps in knowledge and a consensus of priorities for future research initiatives, in order to optimize protection for both the mother and the infant. © Copyright © 2020 Abu-Raya, Maertens, Edwards, Omer, Englund, Flanagan, Snape, Amirthalingam, Leuridan, Damme, Papaevangelou, Launay, Dagan, Campins, Cavaliere, Frusca, Guidi, O'Ryan, Heininger, Tan, Alsuwaidi, Safadi, Vilca, Wanlapakorn, Madhi, Giles, Prymula, Ladhani, Martinón-Torres, Tan, Michelin, Scambia, Principi and Esposito.",
    title = "Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement",
    doi = "10.3389/FIMMU.2020.01282"
}